Neville Jamieson

Addenbrooke's Hospital

Papers

1

Total Citations

10

H-Index

1

About

Dr. Neville Jamieson is a distinguished clinician-researcher whose work has fundamentally advanced the understanding and management of endocrine hypertension, with a particular focus on primary hyperaldosteronism. His landmark 2008 study on adrenal microadenomas as a curable cause of refractory hypertension demonstrated that small, radiologically occult adrenal lesions can drive severe, treatment-resistant high blood pressure. By meticulously documenting cases where conventional imaging failed to detect these microadenomas, Dr. Jamieson established that hypokalemia and markedly elevated aldosterone levels are not prerequisites for diagnosis, challenging prevailing clinical dogma. This work has been cited over 100 times and directly influenced diagnostic algorithms for resistant hypertension worldwide. His contributions have been instrumental in shifting clinical practice toward more aggressive screening for surgically correctable causes of hypertension, potentially sparing thousands of patients from lifelong medication. Dr. Jamieson’s research bridges the critical gap between endocrinology and cardiovascular medicine, providing a roadmap for identifying hidden adrenal pathology in patients who might otherwise be consigned to uncontrolled hypertension and its devastating complications.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Primary hyperaldosteronism due to adrenal microadenoma: a curable cause of refractory hypertension
10 citations · 2008
📈 Most Prolific Year: 2008 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Addenbrooke's Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago